IPP Bureau

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD
Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD

By IPP Bureau - July 18, 2022

Manish led SeQuent since 2014 and played a major role in transforming the company

Glaucoma Research Foundation launches catalyst for a to prevent and cure neurodegeneration
Glaucoma Research Foundation launches catalyst for a to prevent and cure neurodegeneration

By IPP Bureau - July 18, 2022

Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's

Biotium introduces new line of antibodies for exosome detection
Biotium introduces new line of antibodies for exosome detection

By IPP Bureau - July 18, 2022

ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers

Zydus receives final approval from the USFDA for Efinaconazole Topical Solution
Zydus receives final approval from the USFDA for Efinaconazole Topical Solution

By IPP Bureau - July 18, 2022

Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).

Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’

By IPP Bureau - July 18, 2022

Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru

Avet Pharmaceuticals appoints George Svokos as President &CEO
Avet Pharmaceuticals appoints George Svokos as President &CEO

By IPP Bureau - July 18, 2022

George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies

China Pharma submits plan of compliance to NYSE American
China Pharma submits plan of compliance to NYSE American

By IPP Bureau - July 18, 2022

The company was directed to submit a plan of compliance by July 15, 2022

Sumitomo Pharma Oncology receives Orphan Drug Designation for DSP-0390 for the treatment of brain cancer
Sumitomo Pharma Oncology receives Orphan Drug Designation for DSP-0390 for the treatment of brain cancer

By IPP Bureau - July 18, 2022

The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people

Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA

By IPP Bureau - July 16, 2022

ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.

Merck and Orion collaborate for the development and commercialization of ODM-208
Merck and Orion collaborate for the development and commercialization of ODM-208

By IPP Bureau - July 16, 2022

Orion to receive an upfront payment of USD 290 million

UPS Healthcare revolutionizes prioritized shipping with UPS Premier
UPS Healthcare revolutionizes prioritized shipping with UPS Premier

By IPP Bureau - July 16, 2022

Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products

Cellutions BioStorage, a research-to-launch Cryopreservation Bank, inaugurated
Cellutions BioStorage, a research-to-launch Cryopreservation Bank, inaugurated

By IPP Bureau - July 16, 2022

Cellutions BioStorage is a comprehensive biomaterial storage and logistics company with a vision to leverage advanced technologies to serve biopharmaceutical companies

India Health Link join hands with Canopi
India Health Link join hands with Canopi

By IPP Bureau - July 16, 2022

To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India

HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network
HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network

By IPP Bureau - July 16, 2022

Mittal will be driving expansion of the provider network across India

Enveda appoints Vanitha Sekar as Chief Business Officer
Enveda appoints Vanitha Sekar as Chief Business Officer

By IPP Bureau - July 16, 2022

She joins Enveda from Gilead Sciences

Latest Stories

Interviews

Packaging